Clinical Neurology and Neurosurgery
Volume 111, Issue 10 , Pages 858-861, December 2009

Fractionated radiosurgical management of intramedullary spinal cord metastasis: A case report and review of the literature

  • Simul Parikh
    • ,
  • Dwight E. Heron

      Affiliations

    • Corresponding Author InformationCorresponding author at: Department of Radiation Oncology, UPMC Cancer Pavilion, 5150 Centre Avenue, #545, Pittsburgh, PA 15232, United States. Tel.: +1 412 623 6723; fax: +1 412 647 1161.

Department of Radiation Oncology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States

Received 29 January 2009; received in revised form 21 May 2009; accepted 23 June 2009.

Abstract 

Objective and importance

Intramedullary spinal cord metastasis (ISCM) comprises 8.5% of central nervous system metastases and confers significant morbidity. Radioresistant histologies such renal cell carcinoma and melanoma are not generally amenable to long-term palliation with conventional radiotherapy while surgery has often been found to be technically challenging and frequently morbid. In this report, we present a patient with a C5 ISCM from renal cell carcinoma treated with fractionated stereotactic radiosurgery.

Clinical presentation

A 50-year-old gentleman with metastatic renal cell carcinoma presented with profound bilateral shoulder pain and upper extremity paresthesias. Magnetic resonance imaging revealed an intramedullary lesion at the level of fifth cervical vertebra (C5). Medical management and chiropractic manipulation proved to be ineffective. The patient was then treated with external beam radiation therapy, but continued to experience severe pain, paresthesias, and progressive, profound neurologic symptoms.

Intervention

The patient was referred to radiation oncology and neurosurgery for evaluation. Consideration was given to cordotomy and resection but the location and procedure was deemed to be high-risk and therefore was deferred. The decision was made to treat with fractionated stereotactic radiosurgery. A dose of 15Gy was successfully delivered in 3 fractions to the 80% isodose line without complication or adverse effects. Twenty-six months following treatment, the patient was still alive, fully functional, and reported no pain and rare of paresthesias.

Conclusion

Fractionated stereotactic radiosurgery is a feasible, safe, and effective modality for the treatment of ICSM and should be carefully considered in the management of this difficult to treat condition.

Keywords: Palliation, Renal cell carcinoma, Spinal cord metastases, Fractionated stereotactic radiosurgery

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0303-8467(09)00150-4

doi:10.1016/j.clineuro.2009.06.008

Clinical Neurology and Neurosurgery
Volume 111, Issue 10 , Pages 858-861, December 2009

Article Tools

* Image Usage & Resolution